Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Supply, Demand and Key Producers, 2024-2030

Page: 113

Published Date: 07 Dec 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size is expected to reach $ 1926 million by 2030, rising at a market growth of 4.4% CAGR during the forecast period (2024-2030).

AT1R antagonists are compounds that block the binding of angiotensin II to the   Angiotensin II receptor 1 (AT1), thereby inhibiting the biological effects of   angiotensin II. They are primarily used in the treatment of hypertension and   heart failure.

This report studies the global Angiotensin II Type 1 Receptor (AT1R) Antagonists production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Angiotensin II Type 1 Receptor (AT1R) Antagonists and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Angiotensin II Type 1 Receptor (AT1R) Antagonists that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists total production and demand, 2019-2030, (K Units)
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists total production value, 2019-2030, (USD Million)
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists domestic production, consumption, key domestic manufacturers and share
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Angiotensin II Type 1 Receptor (AT1R) Antagonists production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi SA, Novartis, Merck, Aurobindo Pharma Ltd., Takeda Pharmaceutical Co., Ltd., Cosette Pharmaceuticals, Inc., AbbVie, Inc., Shenzhen Salubris Pharmaceuticals Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Angiotensin II Type 1 Receptor (AT1R) Antagonists market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market, Segmentation by Type:
    5mg
    10mg
    20mg
    50mg
    80mg
    100mg
    150mg
    400mg

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market, Segmentation by Application:
    Hospital
    Clinic
    Others

Companies Profiled:
    Sanofi SA
    Novartis
    Merck
    Aurobindo Pharma Ltd.
    Takeda Pharmaceutical Co., Ltd.
    Cosette Pharmaceuticals, Inc.
    AbbVie, Inc.
    Shenzhen Salubris Pharmaceuticals Co., Ltd.

Key Questions Answered:
1. How big is the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market?
2. What is the demand of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market?
3. What is the year over year growth of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market?
4. What is the production and production value of the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market?
5. Who are the key producers in the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Introduction
    1.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Supply & Forecast
        1.2.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value (2019 & 2023 & 2030)
        1.2.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030)
        1.2.3 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Pricing Trends (2019-2030)
    1.3 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Region (Based on Production Site)
        1.3.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Region (2019-2030)
        1.3.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Region (2019-2030)
        1.3.3 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Region (2019-2030)
        1.3.4 North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030)
        1.3.5 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030)
        1.3.6 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030)
        1.3.7 Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Major Market Trends

2 Demand Summary
    2.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Demand (2019-2030)
    2.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption by Region
        2.2.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption by Region (2019-2024)
        2.2.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Forecast by Region (2025-2030)
    2.3 United States Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)
    2.4 China Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)
    2.5 Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)
    2.6 Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)
    2.7 South Korea Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)
    2.8 ASEAN Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)
    2.9 India Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Manufacturer (2019-2024)
    3.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Manufacturer (2019-2024)
    3.3 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Manufacturer (2019-2024)
    3.4 Angiotensin II Type 1 Receptor (AT1R) Antagonists Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Angiotensin II Type 1 Receptor (AT1R) Antagonists in 2023
        3.5.3 Global Concentration Ratios (CR8) for Angiotensin II Type 1 Receptor (AT1R) Antagonists in 2023
    3.6 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Overall Company Footprint Analysis
        3.6.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Region Footprint
        3.6.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Type Footprint
        3.6.3 Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Comparison
        4.1.1 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Comparison
        4.2.1 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Comparison
        4.3.1 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2024)
    4.5 China Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers and Market Share
        4.5.1 China Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value (2019-2024)
        4.5.3 China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2024)
    4.6 Rest of World Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2024)

5 Market Analysis by Type
    5.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 5mg
        5.2.2 10mg
        5.2.3 20mg
        5.2.4 50mg
        5.2.5 80mg
        5.2.6 100mg
        5.2.7 150mg
        5.2.8 400mg
    5.3 Market Segment by Type
        5.3.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Type (2019-2030)
        5.3.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Type (2019-2030)
        5.3.3 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Application (2019-2030)
        6.3.2 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Application (2019-2030)
        6.3.3 World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Sanofi SA
        7.1.1 Sanofi SA Details
        7.1.2 Sanofi SA Major Business
        7.1.3 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.1.4 Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Sanofi SA Recent Developments/Updates
        7.1.6 Sanofi SA Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.2.4 Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Merck
        7.3.1 Merck Details
        7.3.2 Merck Major Business
        7.3.3 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.3.4 Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Merck Recent Developments/Updates
        7.3.6 Merck Competitive Strengths & Weaknesses
    7.4 Aurobindo Pharma Ltd.
        7.4.1 Aurobindo Pharma Ltd. Details
        7.4.2 Aurobindo Pharma Ltd. Major Business
        7.4.3 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.4.4 Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Aurobindo Pharma Ltd. Recent Developments/Updates
        7.4.6 Aurobindo Pharma Ltd. Competitive Strengths & Weaknesses
    7.5 Takeda Pharmaceutical Co., Ltd.
        7.5.1 Takeda Pharmaceutical Co., Ltd. Details
        7.5.2 Takeda Pharmaceutical Co., Ltd. Major Business
        7.5.3 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.5.4 Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Takeda Pharmaceutical Co., Ltd. Recent Developments/Updates
        7.5.6 Takeda Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
    7.6 Cosette Pharmaceuticals, Inc.
        7.6.1 Cosette Pharmaceuticals, Inc. Details
        7.6.2 Cosette Pharmaceuticals, Inc. Major Business
        7.6.3 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.6.4 Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Cosette Pharmaceuticals, Inc. Recent Developments/Updates
        7.6.6 Cosette Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
    7.7 AbbVie, Inc.
        7.7.1 AbbVie, Inc. Details
        7.7.2 AbbVie, Inc. Major Business
        7.7.3 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.7.4 AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 AbbVie, Inc. Recent Developments/Updates
        7.7.6 AbbVie, Inc. Competitive Strengths & Weaknesses
    7.8 Shenzhen Salubris Pharmaceuticals Co., Ltd.
        7.8.1 Shenzhen Salubris Pharmaceuticals Co., Ltd. Details
        7.8.2 Shenzhen Salubris Pharmaceuticals Co., Ltd. Major Business
        7.8.3 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
        7.8.4 Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments/Updates
        7.8.6 Shenzhen Salubris Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Chain
    8.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Upstream Analysis
        8.2.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Core Raw Materials
        8.2.2 Main Manufacturers of Angiotensin II Type 1 Receptor (AT1R) Antagonists Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Mode
    8.6 Angiotensin II Type 1 Receptor (AT1R) Antagonists Procurement Model
    8.7 Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Sales Model and Sales Channels
        8.7.1 Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Model
        8.7.2 Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Region (2019-2024)
 Table 5. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Region (2025-2030)
 Table 6. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Region (2019-2024) & (K Units)
 Table 7. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Region (2025-2030) & (K Units)
 Table 8. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share by Region (2019-2024)
 Table 9. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share by Region (2025-2030)
 Table 10. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Angiotensin II Type 1 Receptor (AT1R) Antagonists Major Market Trends
 Table 13. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption by Region (2019-2024) & (K Units)
 Table 15. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Angiotensin II Type 1 Receptor (AT1R) Antagonists Producers in 2023
 Table 18. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Angiotensin II Type 1 Receptor (AT1R) Antagonists Producers in 2023
 Table 20. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Company Evaluation Quadrant
 Table 22. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Site of Key Manufacturer
 Table 24. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Type Footprint
 Table 25. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market: Company Product Application Footprint
 Table 26. Angiotensin II Type 1 Receptor (AT1R) Antagonists Competitive Factors
 Table 27. Angiotensin II Type 1 Receptor (AT1R) Antagonists New Entrant and Capacity Expansion Plans
 Table 28. Angiotensin II Type 1 Receptor (AT1R) Antagonists Mergers & Acquisitions Activity
 Table 29. United States VS China Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share (2019-2024)
 Table 37. China Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share (2019-2024)
 Table 42. Rest of World Based Angiotensin II Type 1 Receptor (AT1R) Antagonists Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share (2019-2024)
 Table 47. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Type (2019-2024) & (K Units)
 Table 49. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Type (2025-2030) & (K Units)
 Table 50. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Application (2019-2024) & (K Units)
 Table 56. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production by Application (2025-2030) & (K Units)
 Table 57. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Sanofi SA Basic Information, Manufacturing Base and Competitors
 Table 62. Sanofi SA Major Business
 Table 63. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 64. Sanofi SA Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Sanofi SA Recent Developments/Updates
 Table 66. Sanofi SA Competitive Strengths & Weaknesses
 Table 67. Novartis Basic Information, Manufacturing Base and Competitors
 Table 68. Novartis Major Business
 Table 69. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 70. Novartis Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Novartis Recent Developments/Updates
 Table 72. Novartis Competitive Strengths & Weaknesses
 Table 73. Merck Basic Information, Manufacturing Base and Competitors
 Table 74. Merck Major Business
 Table 75. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 76. Merck Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Merck Recent Developments/Updates
 Table 78. Merck Competitive Strengths & Weaknesses
 Table 79. Aurobindo Pharma Ltd. Basic Information, Manufacturing Base and Competitors
 Table 80. Aurobindo Pharma Ltd. Major Business
 Table 81. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 82. Aurobindo Pharma Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Aurobindo Pharma Ltd. Recent Developments/Updates
 Table 84. Aurobindo Pharma Ltd. Competitive Strengths & Weaknesses
 Table 85. Takeda Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 86. Takeda Pharmaceutical Co., Ltd. Major Business
 Table 87. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 88. Takeda Pharmaceutical Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Takeda Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Takeda Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
 Table 91. Cosette Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
 Table 92. Cosette Pharmaceuticals, Inc. Major Business
 Table 93. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 94. Cosette Pharmaceuticals, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Cosette Pharmaceuticals, Inc. Recent Developments/Updates
 Table 96. Cosette Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
 Table 97. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
 Table 98. AbbVie, Inc. Major Business
 Table 99. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 100. AbbVie, Inc. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. AbbVie, Inc. Recent Developments/Updates
 Table 102. AbbVie, Inc. Competitive Strengths & Weaknesses
 Table 103. Shenzhen Salubris Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 104. Shenzhen Salubris Pharmaceuticals Co., Ltd. Major Business
 Table 105. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Product and Services
 Table 106. Shenzhen Salubris Pharmaceuticals Co., Ltd. Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. Shenzhen Salubris Pharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 108. Shenzhen Salubris Pharmaceuticals Co., Ltd. Competitive Strengths & Weaknesses
 Table 109. Global Key Players of Angiotensin II Type 1 Receptor (AT1R) Antagonists Upstream (Raw Materials)
 Table 110. Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Customers
 Table 111. Angiotensin II Type 1 Receptor (AT1R) Antagonists Typical Distributors


List of Figures
 Figure 1. Angiotensin II Type 1 Receptor (AT1R) Antagonists Picture
 Figure 2. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030) & (K Units)
 Figure 5. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Region (2019-2030)
 Figure 7. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share by Region (2019-2030)
 Figure 8. North America Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030) & (K Units)
 Figure 9. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030) & (K Units)
 Figure 10. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030) & (K Units)
 Figure 11. Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Production (2019-2030) & (K Units)
 Figure 12. Angiotensin II Type 1 Receptor (AT1R) Antagonists Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 15. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Market Share by Region (2019-2030)
 Figure 16. United States Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 17. China Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 18. Europe Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 19. Japan Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 22. India Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Angiotensin II Type 1 Receptor (AT1R) Antagonists by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Angiotensin II Type 1 Receptor (AT1R) Antagonists Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Angiotensin II Type 1 Receptor (AT1R) Antagonists Markets in 2023
 Figure 26. United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Angiotensin II Type 1 Receptor (AT1R) Antagonists Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share 2023
 Figure 30. China Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share 2023
 Figure 32. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Type in 2023
 Figure 34. 5mg
 Figure 35. 10mg
 Figure 36. 20mg
 Figure 37. 50mg
 Figure 38. 80mg
 Figure 39. 100mg
 Figure 40. 150mg
 Figure 41. 400mg
 Figure 42. 150mg
 Figure 43. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share by Type (2019-2030)
 Figure 44. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Type (2019-2030)
 Figure 45. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Type (2019-2030) & (US$/Unit)
 Figure 46. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 47. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Application in 2023
 Figure 48. Hospital
 Figure 49. Clinic
 Figure 50. Others
 Figure 51. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Market Share by Application (2019-2030)
 Figure 52. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Production Value Market Share by Application (2019-2030)
 Figure 53. World Angiotensin II Type 1 Receptor (AT1R) Antagonists Average Price by Application (2019-2030) & (US$/Unit)
 Figure 54. Angiotensin II Type 1 Receptor (AT1R) Antagonists Industry Chain
 Figure 55. Angiotensin II Type 1 Receptor (AT1R) Antagonists Procurement Model
 Figure 56. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Model
 Figure 57. Angiotensin II Type 1 Receptor (AT1R) Antagonists Sales Channels, Direct Sales, and Distribution
 Figure 58. Methodology
 Figure 59. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Sanofi SA
Novartis
Merck
Aurobindo Pharma Ltd.
Takeda Pharmaceutical Co., Ltd.
Cosette Pharmaceuticals, Inc.
AbbVie, Inc.
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Related Reports

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Angiotensin II Type 1 Receptor (AT1R) Antagonists Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 07 Dec 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Angiotensin II Type 1 Receptor (AT1R) Antagonists market size was valued at US$ 1429 million in 2023 and is forecast to a readjusted size of USD 1926 million by 2030 with a CAGR of 4.4% during review period.

Product Tags

Angiotensin II Type 1 Receptor (AT1R) Antagonists

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>